ALLIANCE OF CARDIOVASCULAR RESEARCH (EIN 721502598) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

ECKHARD ALT

Phone

8328533898

Tax Period

2024-01-01 to 2024-12-31

ALLIANCE OF CARDIOVASCULAR RESEARCH, founded in 2008, is a micro nonprofit in the Health Care sector that reported $86K in total revenue in fiscal year 2024. Revenue fell 48% from the prior year — a significant decline worth monitoring. Expenses of $805K exceeded revenue, resulting in a 834% operating deficit.

Mission

THROUGH ITS CHARITABLE STATUS, THE ALLIANCE OF CARDIOVASCULAR RESEARCHERS SUPPORTS RESEARCH IN THE FIELD OF CARDIOVASCULAR DISEASES, REGENERATIVE MEDICINE, AND CANCER TREATMENT. SPONSORED PROJECTS FOCUS ON THEIR ABILITY TO MOVE BASIC SCIENCE INTO THE PRACTICE OF MEDICINE. BY KEEPING THE ADMINISTRATIVE OVERHEAD COSTS AT A MINIMUM, VIRTUALLY ALL OF THE BUDGET GOES INTO RESEARCH BY CONDUCTING RESEARCH THROUGH PARTNERING WITH ESTABLISHED UNIVERSITY LABORATORIES AND ACKNOWLEDGED RESEARCH INSTITUTIONS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $0

Investment Income $86,165

Other Revenue $0

TOTAL REVENUE $86,165

Expense Breakdown

Grants Paid $403,919

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $800,837

Other Expenses $400,821

TOTAL EXPENSES $804,740

Year-over-Year Comparison

	2024	2023	Change
Revenue	$86,165	$167,162	-0.5%
Expenses	$804,740	$720,796	+0.1%
Net Income	$-718,575	$-553,634	+0.3%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
RAY BALLANTYNE	DIRECTOR	N/A	Director	$0	$0	$0
ECKHARD ALT	SECRETARY	N/A	Officer	$0	$0	$0
KLAUS KELLER	PRESIDENT/DI	N/A	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$86,165	$804,740	$346,485	$-718,575
2023	$167,162	$720,796	$1,064,560	$-553,634
2022	$55,524	$758,292	$1,618,194	$-702,768
2021	$255,230	$711,796	$2,322,059	$-456,566
2020	$-49,983	$390,321	$2,777,528	$-440,304
2019	$155,716	$621,917	$3,217,832	$-466,201

ALLIANCE OF CARDIOVASCULAR RESEARCH